Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Regorafénib N-oxyde M2 is an active metabolite of Regorafenib. Regorafenib is a multi-target inhibitor for VEGFR1/2/3, PDGFRβ, RET, Kit, and Raf-1 (IC50s: 13/4.2/46, 1.5, 22, 7, and 2.5 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 37.00 | |
2 mg | In stock | $ 51.00 | |
5 mg | In stock | $ 73.00 | |
10 mg | In stock | $ 105.00 | |
25 mg | In stock | $ 189.00 | |
50 mg | In stock | $ 341.00 | |
100 mg | In stock | $ 496.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 90.00 |
Description | Regorafénib N-oxyde M2 is an active metabolite of Regorafenib. Regorafenib is a multi-target inhibitor for VEGFR1/2/3, PDGFRβ, RET, Kit, and Raf-1 (IC50s: 13/4.2/46, 1.5, 22, 7, and 2.5 nM). |
Targets&IC50 | PDGFRβ:1.5nM , c-Kit:7nM , Raf-1:2.5 nM , VEGFR1:13nM , RET:22nM , VEGFR3:46nM , VEGFR2:4.2nM |
Molecular Weight | 498.81 |
Formula | C21H15ClF4N4O4 |
CAS No. | 835621-11-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Slightly soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Regorafénib N-oxyde (M2) 835621-11-9 Angiogenesis Apoptosis MAPK Metabolism Tyrosine Kinase/Adaptors Drug Metabolite c-Kit c-RET PDGFR Raf VEGFR Inhibitor Regorafénib N oxyde (M2) Regorafénib Noxyde (M2) Regorafénib N-oxyde inhibit Regorafénib N-oxyde (M-2) Platelet-derived growth factor receptor inhibitor